Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis

被引:54
作者
Murphy, Sarah E. [1 ]
Bicanic, Tihana [1 ,2 ]
机构
[1] St Georges Univ London, Inst Infect & Immun, London, England
[2] St Georges Univ Hosp Natl Hlth Serv NHS Fdn Trust, Clin Acad Grp Infect & Immun, London, England
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2021年 / 11卷
关键词
Candida; invasive candidiasis; candidaemia; antifungal resistance; antifungal drugs; drug therapy; drug resistance; antimicrobial resistance; BROAD-SPECTRUM ANTIFUNGAL; GLUCAN SYNTHASE INHIBITOR; LONG-ACTING ECHINOCANDIN; IN-VITRO ACTIVITY; INFECTIOUS-DISEASES SOCIETY; CELECOXIB DERIVATIVE AR-12; HIGHLY POTENT INHIBITOR; AMPHOTERICIN-B; MURINE MODEL; TREHALOSE-6-PHOSPHATE PHOSPHATASE;
D O I
10.3389/fcimb.2021.759408
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Candida species are the leading cause of invasive fungal infections worldwide and are associated with acute mortality rates of ~50%. Mortality rates are further augmented in the context of host immunosuppression and infection with drug-resistant Candida species. In this review, we outline antifungal drugs already in clinical use for invasive candidiasis and candidaemia, their targets and mechanisms of resistance in clinically relevant Candida species, encompassing not only classical resistance, but also heteroresistance and tolerance. We describe novel antifungal agents and targets in pre-clinical and clinical development, including their spectrum of activity, antifungal target, clinical trial data and potential in treatment of drug-resistant Candida. Lastly, we discuss the use of combination therapy between conventional and repurposed agents as a potential strategy to combat the threat of emerging resistance in Candida.
引用
收藏
页数:22
相关论文
共 234 条
  • [21] Combining Colistin and Fluconazole Synergistically Increases Fungal Membrane Permeability and Antifungal Cidality
    Bibi, Maayan
    Murphy, Sarah
    Benhamou, Raphael, I
    Rosenberg, Alex
    Ulman, Adi
    Bicanic, Tihana
    Fridman, Micha
    Berman, Judith
    [J]. ACS INFECTIOUS DISEASES, 2021, 7 (02): : 377 - 389
  • [22] Colistin interacts synergistically with echinocandins against Candida auris
    Bidaud, A. L.
    Djenontin, E.
    Botterel, F.
    Chowdhary, A.
    Dannaoui, E.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (03)
  • [23] BioPharma M., 2014, MAT8800 DISC PROGR M
  • [24] Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species
    Borman, Andrew M.
    Szekely, Adrien
    Johnson, Elizabeth M.
    [J]. MSPHERE, 2016, 1 (04):
  • [25] Hyphal orientation of Candida albicans is regulated by a calcium-dependent mechanism
    Brand, Alexandra
    Shanks, Scott
    Duncan, Vanessa M. S.
    Yang, Meng
    Mackenzie, Kevin
    Gow, Neil A. R.
    [J]. CURRENT BIOLOGY, 2007, 17 (04) : 347 - 352
  • [26] A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis
    Brand, Stephen R.
    Degenhardt, Thorsten P.
    Person, Karen
    Sobel, Jack D.
    Nyirjesy, Paul
    Schotzinger, Robert J.
    Tavakkol, Amir
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (06) : 624.e1 - 624.e9
  • [27] VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice
    Break, Timothy J.
    Desai, Jigar V.
    Healey, Kelley R.
    Natarajan, Mukil
    Ferre, Elise M. N.
    Henderson, Christina
    Zelazny, Adrian
    Siebenlist, Ulrich
    Yates, Christopher M.
    Cohen, Oren J.
    Schotzinger, Robert J.
    Perlin, David S.
    Garvey, Edward P.
    Lionakis, Michail S.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (08) : 2089 - 2094
  • [28] VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans
    Break, Timothy J.
    Desai, Jigar V.
    Natarajan, Mukil
    Ferre, Elise M. N.
    Henderson, Christina
    Zelazny, Adrian M.
    Siebenlist, Ulrich
    Hoekstra, William J.
    Schotzinger, Robert J.
    Garvey, Edward P.
    Lionakis, Michail S.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (01) : 151 - 155
  • [29] Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitis
    Brouwer, Annemarie E.
    van Kan, Hendrikus J. M.
    Johnson, Elizabeth
    Rajanuwong, Adul
    Teparrukkul, Prapit
    Wuthiekanun, Vannaporn
    Chierakul, Wirongrong
    Day, Nick
    Harrison, Thomas S.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (03) : 1038 - 1042
  • [30] Antifungal drug resistance evoked via RNAi-dependent epimutations
    Calo, Silvia
    Shertz-Wall, Cecelia
    Lee, Soo Chan
    Bastidas, Robert J.
    Nicolas, Francisco E.
    Granek, Joshua A.
    Mieczkowski, Piotr
    Torres-Martinez, Santiago
    Ruiz-Vazquez, Rosa M.
    Cardenas, Maria E.
    Heitman, Joseph
    [J]. NATURE, 2014, 513 (7519) : 555 - +